Trademarkia Logo

Australia

AU$
EMP
Protected: Registered/protected

Last updated on 27 May 2021

Owner Info

Cygnal Therapeutics, Inc.

325 Vassar Street, Suite 2B

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

2090112 filed on 13 Apr 2020

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

EMP

Classification Information


Class [042]
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of b Read More

Mark Details


Serial Number

2090112

Registered On

13 Apr 2020

Renewal On

13 Apr 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

11 Oct 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
27th May 2021Amendment to Amend Owner Requested
18th Nov 2020International Registration in Australia Protected correspondence sent
17th Nov 2020IP Right Registration Published
17th Nov 2020Status change to Registered/Protected
11th Sept 2020Application Accepted correspondence sent
10th Sept 2020IP Right has been Examined
10th Sept 2020IP Right Acceptance Published
10th Sept 2020Status change to Accepted
21st May 2020Awaiting examination
21st May 2020Examination expedited